UCNQX Performance — Victory Nasdaq-100 Index Fund, Class C
Data updated: 2026-09-29
UCNQX returned +11.42% year to date and +20.83% over one year to Jul 2026. Annualised returns are +20.70% over 3 years and +12.83% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $176, against $153 for the category, and to $121 over one year, against $116. Volatility over the past three years was 17.77% a year. In the 12 months to Jul 2026 the fund lost a net $106.1M, and assets reached $9.01B.
UCNQX Growth of $100
What $100 invested in Victory Nasdaq-100 Index Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | UCNQX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $121 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $176 | $153 |
| 5 years (Aug 2021 – Jul 2026) | $183 | $159 |
| Since data start (Apr 2020 – Jul 2026) | $267 | $253 |
UCNQX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.42% |
| 1 year | +20.83% |
| 3 years (annualised) | +20.70% |
| 5 years (annualised) | +12.83% |
UCNQX Annual Returns
Calendar-year total returns of Victory Nasdaq-100 Index Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +11.42% |
| 2025 | +19.34% |
| 2024 | +24.14% |
| 2023 | +52.86% |
| 2022 | −33.37% |
| 2021 | +25.68% |
| 2020 (Apr–Dec) | +26.47% |
UCNQX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.1% | −2.4% | −4.9% | +15.5% | +10.5% | −0.2% | −6.7% | — | — | — | — | — |
| 2025 | +2.1% | −2.8% | −7.8% | +1.5% | +9.0% | +6.2% | +2.3% | +0.8% | +5.3% | +4.7% | −1.7% | −0.8% |
| 2024 | +1.8% | +5.3% | +1.1% | −4.5% | +6.2% | +6.2% | −1.7% | +1.1% | +2.4% | −0.9% | +5.2% | +0.4% |
| 2023 | +10.5% | −0.5% | +9.4% | +0.4% | +7.6% | +6.4% | +3.7% | −1.6% | −5.2% | −2.1% | +10.7% | +5.4% |
| 2022 | −8.6% | −4.7% | +4.2% | −13.5% | −1.6% | −9.0% | +12.4% | −5.2% | −10.7% | +3.9% | +5.5% | −9.1% |
| 2021 | +0.2% | −0.1% | +1.3% | +5.8% | −1.3% | +6.3% | +2.7% | +4.1% | −5.8% | +7.8% | +1.8% | +1.1% |
| 2020 | — | — | — | 0.0% | 0.0% | 0.0% | +7.3% | +11.0% | −5.8% | −3.3% | +11.0% | +5.0% |
UCNQX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 17.77%
- 3-year Sharpe ratio: 0.91 (vs 4.5% risk-free rate)
- Best month: +15.52% (Apr 2026)
- Worst month: −7.75% (Mar 2025)
UCNQX Fund Flows
Monthly money in and out of Victory Nasdaq-100 Index Fund, from SEC Form N-PORT.
- 12-month net flow: −$106.1M
- 12-month gross sales (incl. reinvestments): $1.4B
- Sales ÷ redemptions: 0.93×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $83.3M | $112.8M | −$29.5M |
| Jun 2026 | $155.5M | $170.1M | −$14.6M |
| May 2026 | $93.9M | $168.0M | −$74.1M |
| Apr 2026 | $115.4M | $126.9M | −$11.5M |
| Mar 2026 | $76.2M | $99.5M | −$23.3M |
| Feb 2026 | $103.5M | $92.0M | $11.5M |
| Jan 2026 | $91.8M | $136.5M | −$44.7M |
| Dec 2025 | $322.1M | $114.1M | $208.0M |
| Nov 2025 | $90.5M | $109.5M | −$19.0M |
| Oct 2025 | $84.2M | $145.5M | −$61.3M |
| Sep 2025 | $66.3M | $92.2M | −$25.9M |
| Aug 2025 | $72.3M | $94.1M | −$21.8M |
UCNQX Assets Under Management
Net assets of Victory Nasdaq-100 Index Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $9.01B |
| 2026-04-30 | $8.85B |
| 2026-01-31 | $8.26B |
| 2025-10-31 | $8.46B |
| 2025-07-31 | $7.69B |
| 2025-04-30 | $6.54B |
| 2025-01-31 | $7.25B |
| 2024-10-31 | $6.79B |
| 2024-07-31 | $6.64B |
| 2024-04-30 | $6.06B |
| 2024-01-31 | $5.89B |
| 2023-10-31 | $4.87B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.